Product Information
TORSEMIDE 5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0573 per EA under NDC 65862012501. Its NADAC has been published 487 times since Nov 28, 2013.
FDA first approved this application on Oct 17, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862012501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TORSEMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078249FDA Approved
10/17/2007
TE Code
AB
On Market Since
10/17/2007
Pharmacological Classes
Price Statistics
The NADAC for TORSEMIDE 5 MG TABLET has been published 487 times since Nov 28, 2013, and over the history we have for it it has declined 57.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0573 per EA |
|---|---|
| All-time high | $0.1742 (Jul 15, 2015) |
| All-time low | $0.0556 (Sep 21, 2022) |
| 52-week high | $0.0677 |
| 52-week low | $0.0573 |
| Median price | $0.0799 |
| Average price | $0.0898 |
| Largest weekly change | +52.2% (Aug 18, 2021) |
| Weeks tracked | 487 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Torsemide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Loop Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TORSEMIDE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TORSEMIDE 5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0573 per EA (NDC 65862012501), effective Sep 30, 2026.
How has the price of TORSEMIDE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TORSEMIDE 5 MG TABLET has declined 57.4%. It has been tracked across 487 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TORSEMIDE 5 MG TABLET?
Since Nov 28, 2013, the NADAC for TORSEMIDE 5 MG TABLET has ranged from a low of $0.0556 (Sep 21, 2022) to a high of $0.1742 (Jul 15, 2015), with a median of $0.0799 per EA.
Are there cheaper alternatives to TORSEMIDE 5 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TORSEMIDE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TORSEMIDE 5 MG TABLET?
TORSEMIDE 5 MG TABLET (NDC 65862012501) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.